Madrigal Pharmaceuticals
Christopher Milazzo is an experienced professional in the pharmaceutical and biotechnology sectors, currently serving as Sr. Director of Clinical Practice Liaisons at Madrigal Pharmaceuticals since July 2024. Previously, Christopher held several leadership roles at AbbVie, including National Director for Field Medical in migraine and Botox Therapeutic, and Director of Regional Medical Science Liaisons. Christopher's extensive experience also includes roles at Allergan as Director of Regional MSLs in migraine and urology, and as President of BioImpact Services, specializing in regulatory approval for biotechnology products. Earlier career achievements include directing commercial processes at Pacific Edge, Ltd., where responsibilities encompassed the establishment of ISO-compliant laboratories and marketing strategies for diagnostic tests. Christopher's academic background features a BS in Animal Sciences from Cornell University and a PhD in Medical and Surgical Sciences from the University of Otago.
This person is not in any teams
This person is not in any offices
Madrigal Pharmaceuticals
4 followers
Madrigal Pharmaceuticals is a clinical-stage biopharmaceutical company pursuing novel therapeutics that target a specific thyroid hormone receptor pathway in the liver, which is a key regulatory mechanism common to a spectrum of cardio-metabolic and fatty liver diseases with high unmet medical need.